Circulating tumor DNA based minimal residual disease detection and adjuvant treatment decision-making for muscle-invasive bladder cancer guided by modern clinical trials

Overview of attention for article published in Translational Oncology, August 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 16 X posts from 15 X users, with an upper bound of 35,907 followers.

@drandy2003 @uniofhertslms

RT @drenriquegrande: 🔘 Circulating tumor DNA based minimal residual disease detection and adjuvant treatment decision-making for muscle-inv…

RT @drenriquegrande: 🔘 Circulating tumor DNA based minimal residual disease detection and adjuvant treatment decision-making for muscle-inv…

RT @drenriquegrande: 🔘 Circulating tumor DNA based minimal residual disease detection and adjuvant treatment decision-making for muscle-inv…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.